Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $103,738 - $186,392
-2,510 Reduced 78.54%
686 $28,000
Q1 2024

May 15, 2024

SELL
$56.27 - $73.77 $1.41 Million - $1.84 Million
-24,976 Reduced 88.66%
3,196 $220,000
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $364,104 - $466,813
6,165 Added 28.01%
28,172 $2.08 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $1.45 Million - $2.18 Million
22,007 New
22,007 $1.5 Million
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $100,797 - $151,164
2,136 New
2,136 $144,000
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $170,336 - $263,043
5,328 Added 32.37%
21,788 $708,000
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $277,259 - $593,526
7,786 Added 89.76%
16,460 $648,000
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $1.13 Million - $1.61 Million
-19,558 Reduced 69.28%
8,674 $606,000
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $372,360 - $517,092
-5,136 Reduced 15.39%
28,232 $2.2 Million
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $2.33 Million - $3.21 Million
25,841 Added 343.31%
33,368 $3.19 Million
Q2 2021

Aug 16, 2021

BUY
$93.66 - $139.27 $597,269 - $888,124
6,377 Added 554.52%
7,527 $936,000
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $86,660 - $123,644
870 Added 310.71%
1,150 $152,000
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $2.21 Million - $3.68 Million
-39,660 Reduced 99.3%
280 $24,000
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $1.31 Million - $3.61 Million
34,609 Added 649.2%
39,940 $2.32 Million
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $99,560 - $127,866
1,282 Added 31.66%
5,331 $493,000
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $398,893 - $540,670
-4,414 Reduced 52.16%
4,049 $365,000
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $988,011 - $1.3 Million
-11,038 Reduced 56.6%
8,463 $999,000
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $1.03 Million - $1.6 Million
16,586 Added 568.99%
19,501 $1.69 Million
Q4 2018

Feb 14, 2019

BUY
$56.04 - $82.66 $126,314 - $186,315
2,254 Added 341.0%
2,915 $184,000
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $686,138 - $991,299
-17,231 Reduced 96.31%
661 $27,000
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $4,091 - $5,324
88 Added 0.49%
17,892 $940,000
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $659,638 - $838,924
17,804
17,804 $839,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.